- LifeSciences - Pharmaceutical
Edenbridge Pharmaceuticals is a well-funded and industry savvy specialty pharmaceutical company focused on identifying, developing and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable and accessible alternatives. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.
Array (  => Alissa Cadigan - RSM US  => Ashley Sarohkian - Capital One  => Badri Nittoor - eureQa  => Benjamin Novak - Morgan Lewis  => Bin Guan - Yorktel  => Blake Goodman - JLL  => Blake Roberts - BDO  => Bret Morgan - CoWerking  => Chris DeMayo - Withum  => Christina Giglio - Robert Half  => David Powell - Mission50  => George Abraham - Rhodium Strategies  => Hitesh Ramani - Deloitte  => Jennifer Lee - Edison Partners  => Joshua Goldberg - Nathlaw  => Kevin Askew - TechXtend  => Kevin Richards - Princeton Identity  => Marc McCabe - Crystal & Company  => Matt DeJesus - ViaWest  => Michael Crafton - Alvarez & Marsal  => Michael Dietze - TierPoint  => Michael Galkin - VoiceNext  => Michelle Capezza - Epstein Becker & Green  => Mike Funk - Alliant Tech  => Mike Profit - WorkWave  => Parag Pruthi - Niksun  => Phil Antoon - Alvareza & Marsal  => Phil Kennard - Futurestay  => Phil Romero - Grant Thornton  => Richard Cleaveland - Eisner Amper  => Ryan Sydorko - EY  => Scott Cowan - DLA Piper  => Tim Dluoik - KPMG  => Timur Pakay - FDU  => Tor Alden - HS Design  => Vijay Ajuwalia - Edward Jones )